What this study is
The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.
What's being tested
- Control Arm ACSM Guidelines
Intervention · OTHER
The control group will follow resistance training guidelines from the American College of Sports Medicine. Eight to ten multi-joint exercises will be performed to stress the major muscle groups.
- Experimental Arm 6-12-25 repetitions per set
Intervention · OTHER
The exercise regimens will employ a mixture of compound exercises utilizing both open and closed kinetic chain movements (CKC), focusing on exercises with the goal of increasing skeletal muscle mass and body composition. The regimen will incorporate 6, then 12, then 25 repetitions in sequence per set per muscle group with minimal amounts of rest between.
Study details
- Official title
- EXERT-BCH: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer to Improve Hypertrophy
- Sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Conditions
- Breast Cancer · Breast Carcinoma in Situ · Breast Cancer Female
- Enrolling
- 30 people
- Starts
- 2024-01-09
- Est. completion
- 2027-01
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 20 Years – 89 YearsSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Age 20-89 years
- Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast
- Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.
You can't join if
- Any current treatment with cytotoxic chemotherapy for breast cancer
- Inability to safely engage in group sessions of resistance training as deemed by study PI
- Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openAllegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Clinical Trials Contact · Contactclinicaltrials@ahn.org
Recruiting
Study team
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Study ID EXERT-BCH
Principal investigator
Colin Champ, MD, CSCS
Radiation Oncologist
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.